Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)
CUSIP: 74365A309
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 80,361,978
- Total 13F shares
- 5,260,461
- Share change
- -735,693
- Total reported value
- $19,818,169
- Price per share
- $3.79
- Number of holders
- 26
- Value change
- -$2,815,871
- Number of buys
- 20
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74365A309:
Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
6%
|
4,828,974
|
$11,348,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.59%
|
477,434
|
$1,122,000 | — | 31 Mar 2020 | |
| Psagot Value Holdings Ltd. |
13F
|
Company |
0.51%
|
406,255
|
$955,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
89,492
|
$210,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
66,631
|
$157,000 | — | 31 Mar 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
50,352
|
$124,000 | — | 31 Mar 2020 | |
| Measured Wealth Private Client Group, LLC |
13F
|
Company |
0.05%
|
38,116
|
$90,000 | — | 31 Mar 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
22,500
|
$53,000 | — | 31 Mar 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
5,969
|
$14,000 | — | 31 Mar 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
5,761
|
$14,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
2,570
|
$6,000 | — | 31 Mar 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1,100
|
$2,585 | — | 31 Mar 2020 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Mar 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Mar 2020 |
Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q2 2020
As of 30 Jun 2020,
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,260,461 shares.
The largest 10 holders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., Phoenix Holdings Ltd., BRIDGEWAY CAPITAL MANAGEMENT INC, BANK OF MONTREAL /CAN/, JANE STREET GROUP, LLC, KENNEDY CAPITAL MANAGEMENT, INC., and ETF MANAGERS GROUP, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
14
Q2 2020 holders
26
Holder diff
12
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.